Antimicrobial activity of aurein 2.5 against yeasts

FEMS Microbiology Letters

Volumn 346, Issue 2, 2013, Pages 140-145

  Dennison, Sarah R ^a   Harris, Frederick ^b   Morton, Leslie H G ^b   Phoenix, David A ^a  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

Alpha helical; Antifungal; Antimicrobial peptide; Monolayer interactions

Indexed keywords

AUREIN 2.5; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ALPHA HELIX; ANTIFUNGAL ACTIVITY; ARTICLE; DRUG STRUCTURE; LIPID MEMBRANE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RHODOTORULA MUCILAGINOSA; SCHIZOSACCHAROMYCES POMBE; YEAST;

RHODOTORULA MUCILAGINOSA; SCHIZOSACCHAROMYCES POMBE;

ALPHA-HELICAL; ANTIFUNGAL; ANTIMICROBIAL PEPTIDE; MONOLAYER INTERACTIONS;

ANTIFUNGAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; LIPIDS; PROTEIN STRUCTURE, SECONDARY; UNILAMELLAR LIPOSOMES; YEASTS;

EID: 84882823649     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/1574-6968.12212     Document Type: Article

References (45)

1. Bligh EG & Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Med Sci 37: 911-917.
2. Bowie JH, Separovic F & Tyler MJ (2012) Host-defense peptides of Australian anurans. Part 2. Structure, activity, mechanism of action, and evolutionary significance. Peptides 37: 174-188.
3. Calzavara-Pinton P, Rossi MT, Sala R & Venturini M (2012) Photodynamic antifungal chemotherapy. Photochem Photobiol 88: 512-522.
4. Dennison SR, Harris F & Phoenix DA (2009a) A study on the importance of phenylalanine for aurein functionality. Protein Pept Lett 16: 1455-1458.
5. Dennison SR, Morton LHG, Shorrocks AJ, Harris F & Phoenix DA (2009b) A study on the interactions of Aurein 2.5 with bacterial membranes. Colloids Surf B Biointerfaces 68: 225-230.
6. Dennison SR, Morton LHG & Phoenix DA (2012a) Role of molecular architecture on the relative efficacy of aurein 2.5 and modelin 5. Biochim Biophys Acta 1818: 2094-2102.
7. Dennison SR, Morton LHG & Phoenix DA (2012b) Effect of amidation on the antimicrobial peptide aurein 2.5 from Australian southern bell frogs. Protein Pept Lett 19: 586-591.
8. Desbois AP, Tschorner D & Coote PJ (2011) Survey of small antifungal peptides with chemotherapeutic potential. Curr Pharm Biotechnol 12: 1263-1291.
9. Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL & Cuenca-Estrella M (2005) Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review. J Antimicrob Chemother 55: 312-316.
10. Harris F & Pierpoint L (2012) Photodynamic therapy based on 5-aminolevulinic acid and its use as an antimicrobial agent. Med Res Rev 32: 1292-1327.
11. Harris F, Dennison SR & Phoenix DA (2009) Anionic antimicrobial peptides from eukaryotic organisms. Curr Protein Pept Sci 10: 585-606.
12. Heinig M & Frishman D (2004) STRIDE: a web server for secondary structure assignment from known atomic coordinates of proteins. Nucleic Acids Res 32: 500-502.
13. Hogberg LD, Heddini A & Cars O (2010) The global need for effective antibiotics: challenges and recent advances. Trends Pharmacol Sci 31: 509-515.
14. Kamysz W, Nadolski P, Kedzia A et al. (2006) In vitro activity of synthetic antimicrobial peptides against Candida. Pol J Microbiol 55: 303-307.
15. Krzysciak P & Macura AB (2010) Drug susceptibility of 64 strains of Rhodotorula sp. Wiad Parazytol 56: 167-170.
16. Martinez L & Fries B (2010) Fungal biofilms: relevance in the setting of human disease. Curr Fungal Infect Rep 4: 266-275.
17. Matejuk A, Leng Q, Begum MD, Woodle MC, Scaria P, Chou ST & Mixson AJ (2010) Peptide-based antifugal therapies against emerging infections. Drugs Future 35: 197-217.
18. Mehra T, Köberle M, Braunsdorf C, Mailänder-Sanchez D, Borelli C & Schaller M (2012) Alternative approaches to antifungal therapies. Exp Dermatol 21: 778-782.
19. Miceli MH, Díaz JA & Lee SA (2011) Emerging opportunistic yeast infections. Lancet Infect Dis 11: 142-151.
20. Morschhaeuser J (2010) Regulation of multidrug resistance in pathogenic fungi. Fungal Genet Biol 47: 94-106.
21. Nunes JM, Bizerra FC, Carmona e Ferreira R & Colombo AL (2013) Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates. Antimicrob Agents Chemother 7: 382-389.
22. Pfaller MA & Diekema DJ (2004) Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 42: 4419-4431.
23. Phoenix DA, Dennison SR & Harris F (2013a) Cationic antimicrobial peptides and their structure/function relationships. Antimicrobial Peptides (Phoenix DA, Dennison SR & Harris F, eds), pp. 39-81. Wiley, Germany.
24. Phoenix DA, Dennison SR & Harris F (2013b) Models for the membrane interactions of antimicrobial peptides. Antimicrobial Peptides (Phoenix DA, Dennison SR & Harris F, eds), pp. 145-180. Wiley, Germany.
25. Prasad R & Goffeau A (2012) Yeast ATP-binding cassette transporters conferring multidrug resistance. Annu Rev Microbiol 66: 39-63.
26. Pukala TL, Bowie JH, Maselli VM, Musgrave IF & Tyler MJ (2006) Host-defence peptides from the glandular secretions of amphibians: structure and activity. Nat Prod Rep 23: 368-393.
27. Rollins-Smith LA (2009) The role of amphibian antimicrobial peptides in protection of amphibians from pathogens linked to global amphibian declines. Biochim Biophys Acta 1788: 1593-1599.
28. Rollins-Smith LA, Ramsey JP, Pask JD, Reinert LK & Woodhams DC (2011) Amphibian immune defenses against chytridiomycosis: impacts of changing environments. Integr Comp Biol 51: 552-562.
29. Seeling A (1987) Local anesthetics and pressure: a comparison of dibucaine binding to lipid monolayers and bilayers. Biochim Biophys Acta 899: 196-204.
30. Somashekar D, Venkateshwaran G, Srividya C, Krishnanand K, Sambaiah K & Lokesh BR (2001) Efficacy of extraction methods for lipid and fatty acid composition from fungal cultures. World J Microbiol Biotechnol 17: 317-320.
31. Stratford M (2006) Food and beverage spoilage yeasts. Yeasts in Food and Beverages (Querol A & Fleet GH, eds), pp. 335-380. Springer, UK.
32. Thomas S, Karnik S, Barai RS, Jayaraman VK & Idicula-Thomas S (2010) CAMP: a useful resource for research on antimicrobial peptides. Nucleic Acids Res 38: D774-D780.
33. Tuon FF & Costa SF (2008) Rhodotorula infection. A systematic review of 128 cases from literature. Rev Iberoam Micol 25: 135-140.
34. Tyler AR, Okoh AO, Lawrence CL, Jones VC, Moffatt C & Smith RB (2013) N-Alkylated 2, 3, 3-trimethylindolenines and 2-methylbenzothiazoles. Potential lead compounds in the fight against Saccharomyces cerevisiae infections. Eur J Med Chem 64: 222-227.
35. Walraven CJ & Lee SA (2013) Antifungal lock therapy. Antimicrob Agents Chemother 57: 1-8.
36. Wang G, Li X & Wang Z (2009) APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res 37: D933-D937.
37. Wazir JF & Ansari NA (2004) Pneumocystis carinii Infection. Arch Pathol Lab Med 128: 1023-1027.
38. Whitmore L & Wallace BA (2004) DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res 32: W668-W673.
39. Whitmore L & Wallace BA (2008) Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases. Biopolymers 89: 392-400.
40. Whitmore L, Woollett B, Miles AJ, Janes RW & Wallace BA (2010) The protein circular dichroism data bank, a Web-based site for access to circular dichroism spectroscopic data. Structure 18: 1267-1269.
41. Wilmes M, Cammue BPA, Sahl H-G & Thevissen K (2011) Antibiotic activities of host defense peptides: more to it than lipid bilayer perturbation. Nat Prod Rep 28: 1350-1358.
42. Wirth F & Goldani LZ (2012) Epidemiology of Rhodotorula: an emerging pathogen. Interdiscip Perspect Infect Dis 2012: 465717. doi: 10.1155/2012/465717.
43. Woodhams DC, Rollins-Smith LA, Carey C, Reinert L, Tyler MJ & Alford RA (2006) Population trends associated with skin peptide defenses against chytridiomycosis in Australian frogs. Oecologia 146: 531-540.
44. Woodhams DC, Ardipradja K, Alford RA, Marantelli G, Reinert LK & Rollins-Smith LA (2007) Resistance to chytridiomycosis varies among amphibian species and is correlated with skin peptide defenses. Anim Conserv 10: 409-417.
45. Yanagida M (2002) The model unicellular eukaryote, Schizosaccharomyces pombe. Genome Biol 3: comment 2003-comment 2003.4 doi:10.1186/gb-2002-3-3-comment2003.